09:48 AM EST - Oncolytics Biotech® Inc. : Today announced recent operational highlights and financial results for the third quarter ended September 30, 2022. During the quarter, the Company reported $32.4 million in cash and cash equivalents. The net loss for the third quarter of 2022 was $4.4 million, compared to a net loss of $4.9 million in the third quarter of 2021. Oncolytics Biotech® Inc.
shares T.ONC are trading up $0.11 at $1.81.
